相关实验视频
Updated: Jul 2, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
自动化胰岛素输送系统使用现实世界的证据
Elizabeth G Considine1, Jennifer L Sherr1
1Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Diabetes technology & therapeutics
|February 20, 2024
概括
自动化胰岛素输送 (AID) 系统显著改善了1型糖尿病 (T1D) 的血糖控制在现实世界中使用,证实了关键试验的好处. 这些先进的技术正在成为标准护理,为T1D患者提供更好的葡萄糖管理.
科学领域:
- 内分泌学和代谢性疾病.
- 医疗技术和设备 医疗技术和设备
- 糖尿病研究研究 糖尿病研究
背景情况:
- 关键试验表明,自动化胰岛素输送系统 (AID) 改善了1型糖尿病 (T1D) 的血糖控制.
- 在现实世界中,AID系统的有效性需要超越受控试验设置进行评估.
研究的目的:
- 评估AID系统的关键试验结果如何转化为现实世界的商业用途.
- 系统地审查对AID在1型糖尿病 (T1D) 的回顾性研究.
主要方法:
- 对2018年以后发表的研究进行PubMed和EMBASE的系统审查.
- 包括5名T1D非怀孕个体的研究,重点关注血糖结果和自动化时间.
- 对20项符合条件的研究进行重复查和数据提取,代表了171,209名个人.
主要成果:
- 大多数研究 (71%) 显示AID的目标范围 (70-180 mg/dL) 的时间改善>10%.
- 观察到HbA1c (0.1%-0.9%) 和葡萄糖管理指标 (GMI) (0.1%-0.4%) 的显著降低.
- 大多数研究报告了在范围以下的时间稳定或减少 (<70 mg/dL),自动化时间>90%.
结论:
- 现实世界的数据证实了关键试验发现,证明了AID在多种T1D种群中的持续的血糖益处.
- 艾滋病辅助系统正在成为T1D管理的标准护理.
- 了解患者的获取,覆盖和支持对于将AID纳入日常生活至关重要.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
172
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
172
Insulin Formulations: Types and Delivery
196
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
196

